Benzyl isothiocyanate triggers apoptosis by initiating autophagy through the generation of ROS and modulating the MAPK and PI3K-AKT pathway in cervical cancer cells
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.115208 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Jing Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Xinjiang Normal University, 830054 Urumqi, Xinjiang, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Isothiocyanates, Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Benzyl isothiocyanate (BITC), a bioactive compound derived from cruciferous vegetables, has demonstrated antitumor potential against cervical cancer; However, its underlying mechanisms remain obscure. Through in vitro and in vivo experiments, this study focuses on unraveling the mechanisms by which BITC inhibits cervical cancer cell proliferation, with a particular emphasis on the relationship between autophagy and apoptosis regulated by oxidative stress and the critical roles of signaling pathways such as MAPK/PI3K-AKT in this process. The findings reveal that BITC exhibits potent cytotoxicity toward cervical cancer HeLa cells, significantly suppressing HeLa colony formation and migration, and inducing apoptosis and reactive oxygen species (ROS) production. Treatment with the autophagy inhibitor 3-methyladenine (3-MA) significantly reduced the proportion of BITC-induced apoptotic cells and the expression of apoptosis-related proteins. Mechanistically, BITC activates the JNK and p38 MAPK pathways while inhibiting the ERK1/2 MAPK and PI3K-AKT axes. However, administration of a JNK inhibitor or ERK/PI3K agonists reversed the BITC-induced expression of autophagy-related protein Beclin 1 and apoptotic protein Cleaved Caspase-3. Additionally, the ROS scavenger N-acetylcysteine abrogated BITC-affected protein expression, including p-JNK, p-ERK, p-PI3K, Beclin 1, and Cleaved Caspase-3. In vivo studies showed that BITC significantly inhibited tumor growth, upregulating the expression of p-JNK, LC3BII/I, Beclin I, Cleaved PARP, and Bax, while downregulating p-ERK, p-AKT, and Bcl-2 proteins. Overall, BITC exerts anti-cervical cancer effects through ROS-driven redox disruption and lethal autophagy induction, modulating MAPK and PI3K-AKT pathways. This finding underscores the potential of BITC for the treatment of cervical cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Sciences, Xinjiang Normal University, 830054 Urumqi, Xinjiang, China.
- Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.
- College of Life Sciences, Xinjiang Normal University, 830054 Urumqi, Xinjiang, China. Electronic address: lijinyu234@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, J., Xie, G., Yang, J., Zhu, C., Zeng, W., Li, X., Yun, Y., Wen, T., Pang, X., Mamat, N., & Li, J. (2025). Benzyl isothiocyanate triggers apoptosis by initiating autophagy through the generation of ROS and modulating the MAPK and PI3K-AKT pathway in cervical cancer cells. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115208
Vancouver
Zhang J, Xie G, Yang J, Zhu C, Zeng W, Li X, et al. Benzyl isothiocyanate triggers apoptosis by initiating autophagy through the generation of ROS and modulating the MAPK and PI3K-AKT pathway in cervical cancer cells. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115208
BibTeX
@article{Zhang2025,
author = {Zhang, Jing and Xie, Guoxuan and Yang, Jun and Zhu, Changqing and Zeng, Weijun and Li, Xinyi and Yun, Yuqing and Wen, Ting and Pang, Xiufeng and Mamat, Nuramina and Li, Jinyu},
title = {Benzyl isothiocyanate triggers apoptosis by initiating autophagy through the generation of ROS and modulating the MAPK and PI3K-AKT pathway in cervical cancer cells},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.115208}
}
EUVIMED